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ABSTRACT
Objectives: Calibrating a disease simulation model’s outputs to existing
clinical data is vital to generate conﬁdence in the model’s predictive ability.
Calibration involves two challenges: 1) deﬁning a total goodness-of-ﬁt
(GOF) score for multiple targets if simultaneous ﬁtting is required, and 2)
searching for the optimal parameter set that minimizes the total GOF
score (i.e., yields the best ﬁt). To address these two prominent challenges,
we have applied an engineering approach to calibrate a microsimulation
model, the Lung Cancer Policy Model (LCPM).
Methods: First, 11 targets derived from clinical and epidemiologic data
were combined into a total GOF score by a weighted-sum approach,
accounting for the user-deﬁned relative importance of the calibration
targets. Second, two automated parameter search algorithms, simulated
annealing (SA) and genetic algorithm (GA), were independently applied
to a simultaneous search of 28 natural history parameters to minimize the
total GOF score. Algorithm performance metrics were deﬁned for speed
and model ﬁt.
Results: Both search algorithms obtained total GOF scores below 95
within 1000 search iterations. Our results show that SA outperformed
GA in locating a lower GOF. After calibrating our LCPM, the predicted
natural history of lung cancer was consistent with other mathematical
models of lung cancer development.
Conclusion: An engineering-based calibration method was able to simul-
taneously ﬁt LCPM output to multiple calibration targets, with the ben-
eﬁts of fast computational speed and reduced the need for human input
and its potential bias.
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Introduction
Simulation modeling and clinical trials offer different and
complementary methods of exploring the relationship between
a health-care intervention and health outcomes. Clinical trials
compare two or more clinical interventions and are able to
describe the comparative effectiveness of the different options.
Nevertheless, most clinical trials have a relatively short time
horizon (2–7 years); by extrapolating from the short-term trial
data, modeling can estimate the longer-term consequences (both
positive and negative) of the intervention. In addition, clinical
trials are very expensive and so rarely evaluate all the clinically
relevant options; modeling can combine the results of several
clinical trials, adjust for trial population differences, and estimate
the incremental differences between options not compared in any
one trial.
In some instances, simulation models incorporate unobserv-
able natural history parameters to model disease development
in patients. Often, estimates of logical relationships between
observable parameters can be established using meta-analysis or
evidence synthesis, but the values of unobservable natural history
parameters must be obtained through the process of model cali-
bration. Calibration is a process of varying the unobservable
parameters until model outputs closely match existing clinical and
epidemiologic data [1]. After the relevant epidemiologic data have
been selected as calibration targets, calibrating the model to those
targets consists of two parts: 1) deﬁning how to simultaneously
measure the level of discrepancy between model output and
multiple calibration targets, and 2) searching for the parameter set
which results in an overall minimization of that discrepancy.
Despite the importance of model calibration, there is no
standard practice in the disease modeling literature for measur-
ing the level of discrepancy between the model output and
the calibration targets. Nor are there standards for how to
search the parameter space such that the best parameter set is
identiﬁed.
Methods of deﬁning the level of discrepancy vary widely.
Some researchers visually match the model output to the clini-
cal data. This methodology is particularly problematic because
it cannot be independently replicated: a different researcher
using the same model may have selected a different parameter
set.
Methods of searching the parameter space also vary widely.
Some researchers manually vary input parameters in their
models, while others use simple parameter search algorithms
such as grid search [2,3] and random search [4]. Grid search
divides each parameter value between the maximum and
minimum values into regular grids. The results of all possible
parameter set combinations are then compared to the calibration
targets. The random search algorithm randomly picks input
parameter sets within the allowable parameter space. Based on
initial results, the allowable parameter region can be modiﬁed or
narrowed, and searched again more thoroughly. Both methods
attempt to locate the optimal parameter values by exhaustively
exploring the whole parameter space. These methods will ﬁnd
the optimal parameter set but are only practical for simulation
models with only a few parameters.
For a disease microsimulation model with many natural
history parameters, grid and random search methods cannot
sample the parameter space efﬁciently. Using a model with 20
unobservable parameters as an example, testing only 10 values
of each unknown parameter with grid or random searches will
require 1020 parameter sets. In practice, researchers would not
test all 1020 sets; typically, results from searching one area of
parameter space are visually inspected and interpreted before
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selecting another area of parameter space to search. Neverthe-
less, even searching a portion of those possibilities would result
in a time-consuming effort.
We sought to adapt calibration methodologies from the
engineering literature that would enable an automated, compu-
tationally feasible, and time-efﬁcient parameter search for com-
prehensive microsimulation models. Two fast parameter search
algorithms commonly used in engineering simulation were
identiﬁed as potentially meeting all of these criteria: simulated
annealing (SA) [5,6] and genetic algorithm (GA) [7,8]. Both
parameter search methods were applied to the Lung Cancer
Policy Model (LCPM) [9–11], a microsimulation model of lung
cancer development, progression, detection, treatment, and sur-
vival. In this article, we have provided examples of using these
two fundamentally different optimization algorithms to perform
the parameter search and compared their performance using
relevant constraints and scenarios comparable to the process
of initially calibrating a model, repeating the calibration of an
individual component, or reﬁning the calibration.
Material and Methods
LCPM
The LCPM is, as a comprehensive model of lung cancer, designed
to evaluate screening [9–11] and other lung cancer control
interventions. A detailed description of all components of the
model is available online at the National Cancer Institute’s
(NCI) Cancer Intervention and Surveillance Modeling Network
(CISNET) Web site (http://cisnet.cancer.gov/proﬁles/), but details
relevant to the current study are provided here. The LCPM
simulates cohorts of individuals with sex-, race-, and birth
cohort-speciﬁc smoking histories as observed for the US popula-
tion [12,13]. In each monthly cycle, a new cancer may develop in
an individual, or an existing cancer may grow, or symptoms may
develop. Lung cancers and benign pulmonary nodules can be
detected through incidental imaging or scheduled screening.
Cancers can also be diagnosed by an evaluation of a patient’s
symptoms. Patients with suspected lung cancer receive diagnostic
and staging tests, and may receive surgical or nonsurgical treat-
ment. Existing cancers may or may not be detected before an
individual dies of their lung cancer or from another cause [14].
Smoking exposure is updated monthly. Model outputs include
estimates of age-speciﬁc lung cancer incidence rates and distri-
butions of lung cancer cell types and stage at diagnosis, as well
as survival by stage at diagnosis.
To reﬂect known heterogeneity of lung cancer and allow the
evaluation of a variety of interventions, the LCPM has a “deep”
underlying natural history model, with cell type-speciﬁc param-
eters for growth, invasiveness, and relationship with smoking
(among others). Simulating the development and progression of
four cell types of lung cancer with such detail required calibrating
the model to estimate values of 87 unobservable natural history
parameters. In this study, we applied the optimization algorithms
to a subset of 28 parameters that describe the development of
new lung cancers (i.e., coefﬁcients in the logistic equations
for each cell type). The remaining 59 parameters related to the
growth, progression, and symptom detection of existing cancers
were not varied and their values were estimated in the previous
calibration exercises.
Three cancers of any of four lung cancer cell types may
develop in each simulated person (adenocarcinoma with or
without bronchioloalveolar carcinoma, large cell, squamous
cell, and small cell), which comprise over 90% of lung cancer.
The monthly probability of developing the ﬁrst malignant cell is
calculated using an independent logistic equation for each cancer
type. Each logistic function has a type-speciﬁc intercept, type-
speciﬁc coefﬁcients for age, age2, years of cigarette exposure
(smoke-years, SY), an interaction term between SY and age2, the
average number of cigarettes smoked per day (cigarettes per day,
CPD), and the years since quitting (YSQ) smoking.
Before beginning the calibration procedure, we eliminated
implausible parameter ranges and assumed correlations between
some parameters on the basis of known relationships between
the incidence of lung cancer by cell type and smoking history. For
example, the baseline risks dictated by the type-speciﬁc intercepts
were ordered to reﬂect the distribution of cell types among non-
smokers [15–18]. Lung cancer risk is also known to increase with
age and smoking experience (SY), and is known to decrease
as the YSQ increases [19–22]. The risk of small cell cancer is the
most dramatically affected by smoking experience, and the effect
of smoking cessation has the weakest effects for developing
adenocarcinoma [17,23]. Thus, the type-speciﬁc coefﬁcient for
SY is required to have the largest magnitude for small cell cancer
and the type-speciﬁc coefﬁcient for YSQ is also required to have
the smallest magnitude for adenocarcinoma.
To account for the changes in unmeasured risk factors
(in addition to the change in smoking pattern) experienced by
different birth cohorts, we incorporated one sex-speciﬁc birth
cohort coefﬁcient, bBY, into the monthly probability of lung
cancer development.
Calibration Targets
With the publication of new biological and medical ﬁndings, new
calibration targets are constantly incorporated into our LCPM.
The version of the LCPM used in this study had 11 calibration
targets (nine primary and two secondary targets), derived from
various data sources. The primary calibration targets were cancer
incidence by cell type, stage-speciﬁc survival, and stage distribu-
tion at diagnosis. Primary targets were extracted from data from
the NCI’s Surveillance, Epidemiology, and End Results (SEER)
Program [24]. The secondary calibration targets were age-
speciﬁc mortality rates of nonsmokers and lung cancer-speciﬁc
mortality ratios for current (vs. never) smokers, derived from
past cohort studies [25] and other literature sources describing
clinical experience [16,18,26,27]. All calibration targets in this
study were derived from only publicly available de-identiﬁed
human subject data.
The discrepancy between the simulation model output
and each calibration target was measured by the goodness-of-ﬁt
(GOF) statistic. We calculated the measure of discrepancy
between each LCPM output to the corresponding calibration
target (i), GOFi, using a sum-of-squared error GOF statistic
(analogous to a chi-square statistic).
Method of Handling Multiple Targets
Calibrating the LCPM to multiple targets simultaneously
required a deﬁnition of a global GOF statistic. We used the
weighted-sum approach [28,29] in which weighting factors were
assigned to all targets in advance of the calibration procedure to
reﬂect the relative importance of the targets. Thus, the summary
GOFsum statistic is a linear combination of the individual
statistics,
GOF W GOFsum i
i
i= ×∑ (1)
where Wi is the weighting factor for the ith target. For the LCPM,
primary calibration targets were given a weight of 1.0 and
secondary calibration targets were given a weight of 0.5 to avoid
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over-ﬁtting to targets with possible measurement issues or dis-
similar populations. Two of the secondary targets are functions
of rare events (lung cancer in never smokers), so the GOF values
for these two targets are large. During the initial exploratory runs
prior to model calibration, the values of the weighting factors
were tested to prevent them from dominating the GOFsum during
the calibration. Their units are in the inverse of the correspond-
ing GOFi, resulting in a unitless GOFsum.
Calibrating to multiple population cohorts. To model the US
population, individual level characteristics such as age at starting
smoking, cigarettes smoked per day, and age of smoking cessa-
tion were generated by “smoking history generator” provided by
NCI’s CISNET (C.M. Anderson, personal communication). Cali-
bration of the model for multiple populations was performed in
a sequential manner, in which we initially calibrated all natural
history parameters, except bBY (set at 1.0), to targets correspond-
ing to the white male cohort born in 1930 to establish the
reference values of the natural history parameters. We then esti-
mated bBY for the remaining cohorts by calibrating the simulation
model to total lung cancer incidence corresponding to white
males and females born between 1920 and 1970.
Parameter Search Algorithms
SA. A ﬂow chart of the SA methodology is shown in Figure 1a.
SA is analogous to the thermodynamics of freezing water or the
crystallization of metal [5,6]. The number of defects in metal can
be reduced by controlling the heating and cooling schedule
during manufacturing. Heating the metal causes atoms to move
from their initial positions and wander randomly (a high “free
energy” state). Slowly cooling the metal to a lower free energy
allows the atoms to ﬁnd the most favorable conﬁguration. The
concept of SA as applied to parameter searching involves the
introduction of an artiﬁcial temperature. At the initial high
temperature, the search algorithm is allowed to widely explore
the parameter space by accepting the parameter values with
higher probabilities. By conceptualizing the model’s GOF as a
surface with peaks (poor ﬁtting parameter sets) and valleys
(better ﬁtting parameter sets), it is apparent that bigger “jumps”
avoid the algorithm falling into a local minimal GOF. Slowly
lowering the temperature allows the search to locate the param-
eter set with the lowest GOF statistic. To test that the algorithm
identiﬁed the unique lowest GOF statistic (the global minimum),
we initiated the SA algorithm in 10 random locations in the
parameter space, with each run limited to 1000 iterations or the
returned GOF value below a predeﬁned stopping value, GOFstop.
See section on Comparison of Search Algorithms for the deﬁni-
tion of GOFstop.
GA. A ﬂow chart of the GA methodology is shown in Figure 1b.
The genetic algorithm is an example of evolutionary algorithms
where the parameter search method is based on the principle of
“survival of the ﬁttest” [7,8]. The initial generation consists of a
population of candidate parameter sets (analogous to chromo-
somes). After running the simulation model with each parameter
set in the original population, the GOF score of each individual
parameter set is stored. The probability of a parameter set being
selected for “reproduction” is proportional to the difference
between its GOF value and the largest GOF value among all
tested parameter sets. The parameter set with the largest GOF
value has a zero probability of reproduction and is eliminated in
the reproduction process. Using a one-point crossover method
[7], the encoded natural history parameters of two parameter
sets are combined to produce a new parameter set, ﬁlling the next
generation. Each newly generated parameter set is subject to
Figure 1 The ﬂow charts of simulated annealing
(SA) and genetic algorithm (GA) are shown. GOF,
goodness-of-ﬁt.
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random changes of individual parameters, with new values
chosen within 10% of the values in either of the parent param-
eter sets (analogous to genetic mutation). In this study, we
permitted the algorithm to repeat until either a total of 1000
parameter sets had been tested (25 generations of 40 chromo-
somes) or a parameter set was identiﬁed yielding a GOF below
the same predeﬁned stopping value (GOFstop) in SA runs.
Comparison of Search Algorithms
We measured and compared the accuracy and speed of SA and
GA parameter search algorithms for calibration of the LCPM
output to the clinically observed data using a cohort of white
males born in 1930. All simulation runs were performed on a
LINUX High-Performance Computing (HPC) Beowulf cluster.
Because the search algorithms incorporate random noise to assist
the parameter exploration process, the returned results from the
search algorithms are stochastic and statistical tests are required
to distinguish their performances.
To compare the ability of each algorithm to ﬁnd the optimal
parameter set efﬁciently, we determined the ability of each algo-
rithm to ﬁnd the lowest GOFsum within a speciﬁed number of
iterations and the amount of time required for each algorithm to
reach a speciﬁc GOFsum target. In the accuracy comparison, each
algorithm was allowed to search through the allowable param-
eter space for a total of 1000 iterations; each iteration simulated
a total of 500,000 hypothetical males. We performed 10 repeats
using each search algorithm: 10 randomly generated starting
parameter sets for SA and 10 randomly generated populations
for GA. The mean minimal GOFsum value, GOFsum
min , from the 10
repeats was used for comparisons.
In the speed comparison, both search algorithms were
allowed to search through the parameter space until they
returned GOFsum below the predeﬁned stopping value, GOFstop.
We recorded the GOFstop as the largest GOFsum
min in the accuracy
comparison. Each search algorithm was repeated 10 times in the
speed comparison test. We distributed the simulation runs to the
HPC Beowulf cluster using one processor per run. To simulate
500,000 individual life histories, the LCPM would require 24
minutes processing time on a dual processor Intel® Pentium®
3.4GHz computer. Because the computational time of the simu-
lation runs is dominated by the calculations of the life histories,
SA and GA require virtually the same amount of real computa-
tional time per iteration on the same processor. The difference in
central processing unit (CPU) time between the two algorithms to
complete 1000 iterations (400 hours) is less than 10 minutes.
Within the cluster, there are seven types of computing nodes with
different processor speeds. Hence, the real computational time
per iteration depends on the hardware. Instead of reporting the
real computational time, we reported the number of iterations
required to reach GOFstop.
In addition to comparing the average values, we also
calculated the 95% conﬁdence intervals (CI) using the following
equation [30]:
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n n
T T z
n n
1 2 2
1
2
1
2
2
2
1 2 1 2 2
1
2
1
2
2
2
−( ) − + < − < −( ) + +α ασ σ μ μ σ σ (2)
where n, T , and s are the number of parameter search runs, the
mean and the SD of the iteration to ﬁnd the stopping GOFsum,
respectively. The subscripts 1 and 2 refer to SA and GA, respec-
tively. From the z-table for the standard normal distribution,
za/2 = 1.96. When lower and upper limits (terms on the left and
right hand sides of m1–m2) of the CI are both negative, SA is faster
than GA with 95% conﬁdence. A similar equation was used for
the accuracy comparison of the minimal GOFsummin.
Recalibrating a Subset of Natural History Parameters
We also examined the abilities of the two parameter search
algorithms to obtain optimal parameter sets in a smaller param-
eter space, a situation often encountered when researchers are
recalibrating a modiﬁed component of a simulation model. After
having established the location of the optimal parameter set, we
repeated the accuracy and speed comparisons when only two
natural history parameters were to be adjusted, speciﬁcally the
type-speciﬁc intercept (b0) of the logistic equations for develop-
ing adenocarcinoma and large cell lung cancer. The results are
compared with the calibration results from the search with 28
parameters.
Face Validation of the Natural History Component
The main objective of model calibration is to obtain values for
the unobserved natural history parameters and the unobserved
biological process, which can not be experimentally determined.
After model calibration, we examined two model predictions of
the natural history of lung cancer development: the lung cancer
risk of current smokers and the temporal trends of lung cancer
risk for different birth cohorts.
Results
Model Calibration with Automated Search Algorithms
Examples of parameter searches. A typical trace of GOFsum
during an SA minimization is shown in Figure 2. At the begin-
ning of the SA run (high temperature), the search algorithm is
allowed to explore all possible parameter values, resulting in
large ﬂuctuations in GOFsum. At the intermediate temperature,
SA avoids being trapped in the local minimum by hopping over
barriers, as indicated by the arrows in Figure 2. At low tempera-
ture, the search algorithm eventually settled on one minimum.
Genetic algorithm evolves the parameter search through
selection and mutation. Figure 3 shows the evolution of GOFsum
as a function of generation number using GA. In the ﬁrst gen-
eration, the randomly generated parameter sets yield a wide
Figure 2 One typical trace of GOFsum is plotted during a simulated annealing
minimization. The arrows indicate three prominent barriers. GOF, goodness-
of-ﬁt.
524 Kong et al.
distribution of the GOFsum values. During each reproduction
cycle, the selection process forces the distribution of the GOFsum
values to converge. At the same time, the random mutations that
occur in each new generation of parameter sets maintain the
heterogeneity in the distribution of GOFsum as shown in Figure 3.
Comparison of search algorithms. We ﬁrst examined the ability
of both algorithms to locate the minimal GOFsum when 28
natural history parameters are allowed to vary simultaneously.
This comparison mimics the situation where researchers are per-
forming the initial model calibration. Within 1000 iterations, SA
was able to achieve a mean minimal GOFsum, GOFsum
min , of 86.5
(range from 80.7 to 90.6) averaging over 10 independent param-
eter searches as shown in Table 1. Within 1000 simulation runs,
GA was able to achieve GOFsum
min of 91.3 (85.2 to 94.1). The 95%
CI is: -7.56 < m1 - m2 < -2.03. The upper and lower limits of the
CI are both negative, indicating that SA is more efﬁcient than GA
in locating the lowest GOFsum.
The stopping GOFsum value for the speed comparison was
selected as 95 based on the rounded largest GOFsummin value
obtained from GA, reﬂecting a typical scenario in which a
parameter set must be chosen within a budgeted computational
time. For the speed comparison, choosing the high stopping value
also prevents the complication of some runs not achieving
the stopping GOFsum. We measured the number of iterations
required to reach a GOFsum < 95 where all 28 natural history
parameters were available to be adjusted. This comparison
mimics the case where the researchers are recalibrating the model
and an estimated value of GOFsum
min was previously established. In
this scenario, SA required an average of 202 iterations to reach
a GOFsum of 95. Under the same scenario, GA required an
average of 294 iterations to reach a GOFsum of 95. The values
for the means and the SD are shown in Table 2. The 95% CI is
-216.7 < m1 - m2 < 32.9. Because the two limits have opposite
signs, no signiﬁcant difference in speed was found between the
two algorithms.
In addition to the 28 parameter searches, we have also exam-
ined the abilities of the two algorithms to search through only
two-parameter space. In Figure 4, the GOFsum
min values are plotted
for both 2 and 28 parameter searches. Except for the result for
GA in the 28 parameter search, all of the GOFsum
min
values are
below 90. The average search times are plotted in Figure 5.
Going from 2 to 28 parameters increased the search time by
230% and 280% for SA and GA, respectively.
The model outputs corresponding to the parameter sets with
the lowest GOFsummin for both algorithms (80.7 for SA and 85.2 for
GA) are shown in Figure 6 for selected calibration targets: overall
incidence, distribution of cell type, and stage distribution of
incident cancers. Both SA and GA obtained similar good ﬁts for
each of the calibration targets. Model outputs versus the remain-
ing targets are available online (http://www.cisnet.cancer.gov/
proﬁles).
Face Validation of Natural History Component
After model calibration, we investigated two model predictions
for the natural history of lung cancer: the monthly probability of
lung cancer development as a function of age and cigarettes
smoked per day, and the temporal trends of lung cancer risk in
the US population.
Figure 3 The GOFsum scores are plotted as a function of generation number.
Each circle in the graph represents the returned GOFsum score from one
chromosome. There are 40 chromosomes in each generation. In this case,
genetic algorithm found an acceptable minimum after 20 generations. GOF,
goodness-of-ﬁt.
Table 1 The comparison of the search results for ﬁxed number of
search iterations. The lower and upper limits of the 95% conﬁdence
interval around m1–m2 are -7.56 to -2.03
GOFsum
min
s n
SA 86.5 2.87 10
GA 91.3 3.41 10
GA, genetic algorithm; GOF, goodness-of-ﬁt; SA, simulated annealing.
Figure 4 The returned minimum averaged over 10 runs for simulated anneal-
ing (SA) and genetic algorithm (GA) with different number of parameters.
For each search run, the algorithm is allowed to perform 1000 iterations.
Table 2 The statistics of the results obtained from SA and GA. The
indexes 1 and 2 are for SA and GA, respectively. The values of T are
measured and reported as the average number of iterations among 10
runs. The lower and upper limits of the 95% conﬁdence interval is
-216.7 < m1–m2 < 32.9
T s n
SA 202 113.9 10
GA 294 166.2 10
GA, genetic algorithm; SA, simulated annealing.
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Monthly probability of lung cancer development. Because both
SA and GA obtained similar good ﬁts, we only show results using
the best parameter set from SA to examine our model prediction
for lung cancer development. Figure 7 shows the monthly prob-
abilities of cancer development as a function of both age and
CPD. The best natural history parameter set shows a peak in the
monthly probability of developing the ﬁrst malignant lung cancer
cell near age 76 years, followed by a decrease in the monthly
probability of developing lung cancer at older ages. This decreas-
ing trend has been predicted by other published theories:
increased tumor suppressor protection with age [31], and the loss
of proliferative ability in senescent cells [32].
Population trends in lung cancer. Figure 8 shows the comparison
between model outputs and SEER incidence rates for white males
born between 1975 and 2000. Figure 9 shows the effect of birth
year on lung cancer risk, stratiﬁed by sex. For both sexes, the
trends level off after the 1950s. The temporal trend for females
shows a peak around 1930. Published mathematical models
obtained similar results [33–37].
Figure 5 The search times averaged over 10 runs for simulated annealing (SA)
and genetic algorithm (GA) with different number of parameters are shown.
The search time is deﬁned as the iteration at which the search algorithm ﬁrst
ﬁnds a GOFsum value below 95.
a
c d
b
Figure 6 Using the returned optimal parameter set from simulated annealing (SA) and genetic algorithm (GA) as inputs, the model outputs versus corresponding
calibration targets for a) overall incidence, b) distribution of cell type, and stage distribution of c) nonsmall cell and d) small cell lung cancers for white males born
in 1930 are shown. SEER, Surveillance, Epidemiology, and End Results.
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Discussion
Motivated by the lack of a standard procedure to calibrate
disease simulation models in the literature, we have adapted an
engineering approach to calibrate the LCPM. This approach can
simultaneously shorten the time spent on model calibration and
minimize human-induced bias. With the ongoing release of new
medical information, the LCPM is constantly being modiﬁed.
This automated calibration approach is able to reduce the burden
of model calibration and allows researchers to focus on model
development and data analysis.
Our approach is a general procedure that can be applied
to other microsimulation models. We suggest a weighted-sum
approach for combining multiple targets. When we varied
28 natural history parameters, our results indicate that SA is
superior in locating the lowest GOFsum. When a stopping rule is
imposed by deﬁning a speciﬁc acceptable level of GOFsum, the
average search time of SA is faster than the GA but not signiﬁ-
cantly. For two natural history parameters, both algorithms
perform equally well in model calibration. SA and GA are both
faster than grid search, because in grid search, the computational
time increases as a power function of the number of parameters
as described in the introduction. This makes both SA and GA
extremely attractive for calibrating disease models with a large
number of parameters. Our results show that SA is better than or
as good as GA in one of the two calibration scenarios. SA would
be a better choice for researchers considering advanced search
algorithm for automated calibration.
Our model prediction of the monthly probability of develop-
ing adenocarcinoma showed a downturn in lung cancer risk at
old age. This prediction was not assumed in advance; it was
purely a result of calibrating our LCPM but is in agreement with
recent biological theories based on observed epidemiologic data
[31,32]. These theories still need to be veriﬁed by future clinical
studies. Our approach of using logistic equations for lung cancer
development is ﬂexible enough to capture the observed epide-
miologic trend of lung cancer incidence at older age.
Our results indicate that the lung cancer risks (all cell types
combined) of white female birth cohorts decreased from 1920
to 1945 and then leveled off. For white females, the temporal
risk shows an initial increase, peaks around birth year 1930,
decreases between 1930 and 1950, and eventually levels off.
Because population trends in smoking patterns were already
incorporated by using the CISNET smoking history generator,
additional effects such as increasing use of cigarette ﬁlters and
improvement of the overall population health may have contrib-
uted to the decrease in the lung cancer risk for the younger birth
cohorts. In Figure 8, the LCPM overpredicted the lung cancer
incidence for the youngest cohort, indicating that the lung cancer
natural history of the youngest cohort is substantially different
from the reference cohort of the white male born in 1930. Our
method of using a single birth cohort coefﬁcient, bBY, may not
adequately capture the dramatic changes in population trends
such as increasing use of cigarette ﬁlters and its effects on differ-
ent lung cancer subtypes. In the future, we will expand bBY to
four cell types. The observed lung cancer incidences of different
cell types will be used as calibration targets to improve our
population calibration.
Manual parameter tuning, grid and random searches are
inadequate to calibrate simulation models with large numbers of
natural history parameters. The combination of weighted-sum
method and automated parameter search algorithms offers an
attractive solution for disease modelers. Our results demonstrated
that this engineering approach is capable of calibrating a disease
model with a large number of natural history parameters. The
Figure 7 The monthly probability of cancer development for adenocarcinoma,
Padeno, is shown as a function of both age and average cigarettes smoked per day,
CPD.
Figure 8 The model outputs are calibrated to the white male population in
United States. SEER, Surveillance, Epidemiology, and End Results.
Figure 9 After calibrating the Lung Cancer Policy Model to the white popu-
lation in the United States, bBY is shown as a function of birth year.The results
show clear sex and birth year dependencies in the monthly risk of cancer
development.
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advantages of this novel approach are 1) estimating the natural
history parameters within an acceptable time, and 2) reducing
human bias in the parameter search. Adapting this engineering
approach also facilitates transparent communication of model
calibration procedures by specifying the search algorithm.
This comparison has several limitations. First, we have not
formally examined the effects of varying the ranges of allowable
parameter values on the search time and accuracy of search
algorithms. The best GOFsum values are obtained within the
estimated allowable parameter ranges. There are potentially
lower GOFsum values outside of the allowable parameter ranges.
Second, epidemiologic studies have shown changing patterns
of lung cancer incidence that are both sex and histologic type-
speciﬁc [33,38–41]. Nevertheless, such effects can not be cap-
tured by the current sex-speciﬁc birth-cohort coefﬁcient, bBY.
Future expansion of the model will incorporate sex-speciﬁc birth
cohort coefﬁcients for each histologic lung cancer type.
Because of the limited time and computing resources, our
approach to model calibration only explores one method of
handling multiple calibration targets and two automated param-
eter search algorithms. In the engineering literature, there exist
many excellent review articles on other techniques of optimiza-
tion [5–8,42]. Other disease modelers are encouraged to consider
using this literature to further develop calibration procedures in
disease natural history modeling.
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